The Association of Vitamin D Deficiency and Incident Frailty in Older Women: The Role of Cardiometabolic Diseases. Issue 3 (23rd December 2016)

• Record Type: Journal Article
• Authors: Buta, Brian; Choudhury, Parichoy Pal; Xue, Qian‐Li; Chaves, Paulo; Bandeen‐Roche, Karen; Shardell, Michelle; Semba, Richard D.; Walston, Jeremy; Michos, Erin D.; Appel, Lawrence J.; McAdams‐DeMarco, Mara; Gross, Alden; Yasar, Sevil; Ferrucci, Luigi; Fried, Linda P.; Kalyani, Rita Rastogi
• Is Part Of: Journal of the American Geriatrics Society. Volume 65:Issue 3(2017:Mar.)
• Page Start: 619
• Page End: 624
• Publication Date: 2016-12-23
• Subjects: aging -- vitamin D -- frailty -- cardiometabolic diseases; Geriatrics -- Periodicals; 618.97
• DOI: 10.1111/jgs.14677
• Languages: English
• ISSNs: 0002-8614

Abstract

Abstract : Objectives: Evidence suggests vitamin D deficiency is associated with developing frailty. However, cardiometabolic factors are related to both conditions and may confound and/or mediate the vitamin D–frailty association. We aimed to determine the association of vitamin D concentration with incidence of frailty, and the role of cardiometabolic diseases (cardiovascular disease, diabetes, hyperlipidemia, hypertension) in this relationship. Design: Prospective longitudinal cohort study (7 visits from 1994–2008). Setting: Baltimore, Maryland. Participants: Three hundred sixty‐nine women from the Women's Health and Aging Study II aged 70–79 years, free of frailty at baseline. Measurements: Serum circulating 25‐hydroxyvitamin D (25[OH]D) concentration was assessed at baseline and categorized as: <10; 10–19.9; 20‐29.9; and ≥30 ng/mL. Frailty incidence was determined based on presence of three or more criteria: weight loss, low physical activity, exhaustion, weakness, and slowness. Cardiometabolic diseases were ascertained at baseline. Analyses included Cox regression models adjusted for key covariates. Results: Incidence rate of frailty was 32.2 per 1, 000 person‐years in participants with 25(OH)D < 10 ng/mL, compared to 12.9 per 1, 000 person‐years in those with 25(OH)D ≥ 30 ng/mL (mean follow‐up = 8.5 ± 3.7 years). In cumulative incidence analyses, those with lower 25(OH)D exhibited higher frailty incidence, though differences were non‐significant ( P = .057). In regression models adjusted for demographics, smoking, and season, 25(OH)D < 10 ng/mL (vs ≥30 ng/mL) was associated with nearly three‐times greater frailty incidence (hazard ratio (HR) = 2.77, 95% CI = 1.14, 6.71, P = .02). After adjusting for BMI, the relationship of 25(OH)D < 10 ng/mL (vs ≥30 ng/mL) with incident frailty persisted, but was attenuated after further accounting for cardiometabolic diseases (HR = 2.29, 95% CI = 0.92, 5.69, P = .07). Conclusion: Low serum vitamin D concentration is associated with incident frailty in older women; interestingly, the relationship is no longer significant after accounting for the presence of cardiometabolic diseases. Future studies should explore mechanisms to explain this relationship.